Comparative evaluation of IV ketorolac and IV paracetamol in laparoscopic surgeries: a systematic review and meta-analysis
Abstract
Background: Effective postoperative pain control is essential for enhanced recovery after laparoscopic surgery. Intravenous ketorolac and paracetamol are widely used non-opioid agents in multimodal analgesia, but their relative efficacy and safety remain controversial. Methods: Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines, databases were searched through September 2025 for randomized and comparative studies of intravenous (IV) ketorolac versus IV paracetamol. Pooled effect estimates with 95% confidence intervals were calculated using RevMan 5.4. The primary outcome was postoperative visual analog scale (VAS) pain scores; secondary outcomes included the timing and use of rescue analgesia, hemodynamic parameters, and adverse events. Results: Eight studies encompassing 540 patients met inclusion criteria. IV ketorolac significantly reduced VAS scores at 2 hours (MD = −0.95; 95% CI: −1.17 to −0.74; P < 0.00001), 4 hours (MD = −0.99; 95% CI: −1.62 to −0.35; P = 0.002), and 8 hours (MD = −0.45; 95% CI: −0.78 to −0.13; P = 0.006) postoperatively compared with IV paracetamol. The time to first rescue analgesia was significantly longer with ketorolac (MD = 1.93; 95% CI: 1.26–2.61; P < 0.00001). Postoperative vomiting occurred less frequently with ketorolac, while other adverse events and hemodynamic parameters were comparable between the groups. Substantial statistical heterogeneity was present for some outcomes. Conclusion: Intravenous ketorolac provides better early postoperative analgesia and longer-lasting pain relief than intravenous paracetamol following laparoscopic surgery, without increased adverse events. Vomiting was also less frequent with ketorolac. Both agents showed acceptable short-term safety and may be used for multimodal, opioid-sparing analgesia guided by patient and procedural factors.